1. Home
  2. FONR vs NSPR Comparison

FONR vs NSPR Comparison

Compare FONR & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fonar Corporation

FONR

Fonar Corporation

HOLD

Current Price

$14.45

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.95

Market Cap

81.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FONR
NSPR
Founded
1978
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.3M
81.8M
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
FONR
NSPR
Price
$14.45
$1.95
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
30.3K
64.4K
Earning Date
11-10-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.08
N/A
Revenue
$105,434,318.00
$7,779,000.00
Revenue This Year
N/A
$22.76
Revenue Next Year
N/A
$75.45
P/E Ratio
$13.40
N/A
Revenue Growth
3.36
14.04
52 Week Low
$12.00
$1.59
52 Week High
$17.62
$3.80

Technical Indicators

Market Signals
Indicator
FONR
NSPR
Relative Strength Index (RSI) 47.38 47.94
Support Level $14.35 $1.89
Resistance Level $15.19 $2.17
Average True Range (ATR) 0.30 0.14
MACD 0.01 0.02
Stochastic Oscillator 39.04 50.00

Price Performance

Historical Comparison
FONR
NSPR

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: